Angelos Konstas, MD
Diagnostic Radiology · Pasadena, CANPI 1881744480
Payments from drug & device makers
Across 67 payments — averaging $410.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$13K
- Medtronic$13K
- Medical Device Business Services, Inc.$1K
- Viz.ai, Inc.$198
- Abbott$125
- Life Molecular Imaging Ltd$69
- plus $292 from 9 others
What the payments were for
- Consulting fees$2,76457%
- Food & beverage$2,06343%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 11 | $12,954 |
| Medtronic(2 entities) | 35 | $12,674 |
| Medical Device Business Services, Inc. | 1 | $1,188 |
| Viz.ai, Inc. | 1 | $198 |
| Abbott | 6 | $125 |
| Life Molecular Imaging Ltd | 2 | $69 |
| GE HealthCare | 2 | $58 |
| Cardiva Medical, Inc. | 1 | $43 |
| Philips North America LLC | 2 | $37 |
| Bard Peripheral Vascular, Inc. | 1 | $34 |
| Johnson & Johnson | 1 | $34 |
| Siemens Medical Solutions USA, Inc. | 1 | $26 |
| Boston Scientific | 1 | $22 |
| Imperative Care, Inc | 1 | $21 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYPHON EXPRESS II KYPHOPAK TRAY$1,275
- Viz.AI LVO$198
- Axium$178
- Pipeline$167
- TREVO$112
- Solitaire$111
How this compares
$27,499 in reported general payments places this provider in the 95th percentile of 3,537 diagnostic radiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 81 | $281 |
| Atorvastatin Calcium | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other diagnostic radiology in Pasadena
- Michael WangEscondido$14M
- Murray ReicherSan Diego$10.5M
- Charles PeterfyKentfield$8.1M
- Garry GoldStanford$6M
- Gary UlanerLos Angeles$3.3M
- Jerome BarakosSan Francisco$2.5M
- Armonde BaghdanianLos Angeles$2.1M
- Curtis LanglotzStanford$1.8M
- Albert HsiaoSan Diego$1.6M
- Matthew LungrenSan Francisco$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.